Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 3Polfa Tarchomin
02 4Advanced
03 1Alexon Healthcare
04 2Antibiotice SA
05 1Anwita Drugs & Chemicals Pvt Ltd
06 2Chongqing Huapont Pharmaceutical Co. Ltd
07 1Reyoung pharmaceutical
08 1Shenyang Shuangding Pharmaceutical
09 3Umedica Laboratories Pvt Ltd
10 2Varichem Pharmaceuticals Pvt Ltd
01 1Isoniazid; Pyrazinamide; Rifampicin
02 6Rifampicin
03 12Rifampin
04 1Rifampin; Isoniazid
01 4CAPSULE
02 3Capsule
03 3Hard Capsule
04 4Injection
05 1PELLET
06 1Powder for Injection
07 1SUSPENSION
08 2capsules
09 1Blank
01 10.45g
02 1100MG/5ML
03 7150MG
04 1150MG; 100MG
05 1150MG; 375MG; 150MG
06 4300MG
07 1300MG/5ML
08 2450MG
09 160%
10 1600MG
01 4China
02 5India
03 3Poland
04 2Romania
05 4Russia
06 2Zimbabwe
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 150MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 300MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 150MG; 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 450MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 450MG
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Powder for Injection
Dosage Strength : 0.45g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging :
Regulatory Info :
Dosage : Powder for Injection
Dosage Strength : 0.45g
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging : Blister of 10s
Approval Date :
Application Number : 90034
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 150MG
Brand Name : URIFA
Approval Date :
Application Number : 90034
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 300MG
Packaging : Blister of 10s
Approval Date :
Application Number : 90034
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 300MG
Brand Name : URIFA
Approval Date :
Application Number : 90034
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 450MG
Packaging : Blister of 10s
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 450MG
Brand Name : URIFA
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : Zimbabwe
Brand Name : Rifacure
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Zimbabwe
Packaging :
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 150MG
Brand Name : Rifacure
Approval Date :
Application Number :
Registration Country : Zimbabwe
Regulatory Info : Generic
Registration Country : Zimbabwe
Brand Name : Rifacure
Dosage Form : SUSPENSION
Dosage Strength : 100MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Zimbabwe
Packaging :
Regulatory Info : Generic
Dosage : SUSPENSION
Dosage Strength : 100MG/5ML
Brand Name : Rifacure
Approval Date :
Application Number :
Registration Country : Zimbabwe
